Risk factors for relapse after reinduction treatment with rituximab in patients with antineutrophil cytoplasmic ...

Serum CXCL6 was higher in ANCA-associated vasculitis with interstitial lung disease and independently predicted ILD ...

Serum DKK1 measured at diagnosis correlated with AAV activity and identified patients at higher risk of end stage kidney ...

Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) is a severe autoimmune condition in which circulating autoantibodies target components of neutrophils, notably proteinase 3 and ...

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comes with a heavy quality-of-life burden that doesn't ...

A high rate of thyroid disease is found among patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV), particularly during the 5 years following AAV diagnosis. A high rate of ...

Please provide your email address to receive an email when new articles are posted on . Avacopan was associated with fewer serious adverse events than controls in ANCA-associated vasculitis. Data from ...

Prophylactic treatment with trimethoprim-sulfamethoxazole (TMP-SMX) significantly reduced the risk for serious infections by approximately 50% in patients with antineutrophil cytoplasmic antibody ...

Patients with GCA or AAV were associated with an increased risk for hospitalization due to pneumonia compared with members of the general population.

The updated 2025 BSR management recommendations for patients with AAV provide systematic and evidence-based recommendations to support UK clinicians in managing AAV across the entire life course.

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months. Stay ahead of policy, cost, and value—subscribe to AJMC for expert ...